Relpax

ROERIG🇺🇸 United States

FDA Page

Effective Date: Mar 11, 2020
Approval ID: 85745375-fcb6-4edc-b6db-a77b4a5f3e8c
Products: 2 registered
Version: 21

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RELPAX safely and effectively. See full prescribing information for RELPAX. RELPAX® (eletriptan hydrobromide) tablets, for oral use Initial U.S. Approval: 2002

Quick Stats

Total Products2

Labelers2

Label Sections21

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.